Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals

ENGLEWOOD, Colo. & SAN DIEGO–(BUSINESS WIRE)–Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc. (OTCQB: INNV), a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer health products, today announced that the companies have signed a definitive merger agreement whereby Aytu will retire all outstanding common st

Click to view original post